glp-1 approved for pcos fda New GLP-1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity Your Body Isn't Broken: How

But states may remain reluctant to offer the expensive drugs for obesity, because Medicaid recipients frequently churn on and off the coverage as their income changes

Arch Bronconeumol

Ibrahim, T

A particularly concerning condition associated with these drugs is stomach paralysis, or gastroparesis, a chronic condition where the stomach takes longer to empty its contents and potentially leads to blockages, resulting in significant discomfort and potentially severe complications

What this means for pricing: vendors operating in this space face lower regulatory compliance costs than pharmaceutical companies, which is partly why research-grade retatrutide costs a fraction of what the eventual FDA-approved version will cost